Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fraser Cunningham

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|June 28, 2016
Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamidesEleni Pitta, Maciej K Rogacki, Olga Balabon, et al.
Bulletin of Mathematical Biology|February 17, 2020
Mathematical Modelling of Alternative Pathway of Complement SystemSuruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, et al.
Bulletin of Mathematical Biology|December 19, 2021
Correction to: Mathematical Modelling of Alternative Pathway of Complement SystemSuruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, et al.
Structure (London, England : 1993)|May 24, 2022
Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activityAnna Czarna, Jacek Plewka, Leanid Kresik, et al.
Journal of Medicinal Chemistry|December 1, 2018
Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 InhibitorsMaciej K Rogacki, Eleni Pitta, Olga Balabon, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Testing tuberculosis drug efficacy in a zebrafish high-throughput translational medicine screenAnita Ordas, Robert-Jan Raterink, Fraser Cunningham, et al.
Journal of Medicinal Chemistry|April 29, 2020
Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) InhibitorsOlga Balabon, Eleni Pitta, Maciej K Rogacki, et al.
Plos One|July 16, 2021
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia Dee Cesare, et al.
Plos One|April 16, 2024
Correction: Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia De Cesare, et al.
ACS Infectious Diseases|March 21, 2020
Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic MetaboliteFraser Cunningham, Jorge Esquivias, Raquel Fernández-Menéndez, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|June 28, 2016
Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamidesEleni Pitta, Maciej K Rogacki, Olga Balabon, et al.
Bulletin of Mathematical Biology|February 17, 2020
Mathematical Modelling of Alternative Pathway of Complement SystemSuruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, et al.
Bulletin of Mathematical Biology|December 19, 2021
Correction to: Mathematical Modelling of Alternative Pathway of Complement SystemSuruchi Bakshi, Fraser Cunningham, Eva-Maria Nichols, et al.
Structure (London, England : 1993)|May 24, 2022
Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activityAnna Czarna, Jacek Plewka, Leanid Kresik, et al.
Journal of Medicinal Chemistry|December 1, 2018
Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 InhibitorsMaciej K Rogacki, Eleni Pitta, Olga Balabon, et al.
Antimicrobial Agents and Chemotherapy|November 12, 2014
Testing tuberculosis drug efficacy in a zebrafish high-throughput translational medicine screenAnita Ordas, Robert-Jan Raterink, Fraser Cunningham, et al.
Journal of Medicinal Chemistry|April 29, 2020
Optimization of Hydantoins as Potent Antimycobacterial Decaprenylphosphoryl-β-d-Ribose Oxidase (DprE1) InhibitorsOlga Balabon, Eleni Pitta, Maciej K Rogacki, et al.
Plos One|July 16, 2021
Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia Dee Cesare, et al.
Plos One|April 16, 2024
Correction: Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodiesLee A Armstrong, Sven M Lange, Virginia De Cesare, et al.
ACS Infectious Diseases|March 21, 2020
Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic MetaboliteFraser Cunningham, Jorge Esquivias, Raquel Fernández-Menéndez, et al.
Pageof 3